We will be attending the 2205 ESMO Congress, taking place Oct 17-21, in Berlin, Germany. Review our poster and partner poster presentations below.
Featured Presentations
Scientific Posters
Validation of an epigenomic-based multicancer detection test
Presenter: Stephen R. Quake, Stanford University
Presentation Number: 1745P
Evaluation of a cell-free DNA-based blood test for early detection of pancreatic cancer in high-risk individuals with family history and genetic predisposition
Presenter: Randall Brand, University of Pittsburgh
Presentation Number: 2245P
SAFE-D trial design: Targeted pancreatic cancer surveillance to evaluate resectability rate and stage shift in patients with new onset diabetes
Presenter: Victoria Goss, Southampton Clinical Trials Unit
Presentation Number: 2255TiP
e-Posters
Epigenomic Multicancer Detection Algorithms Capture Disease Biomarkers through Machine Learning
Presenter: Stephen R. Quake, Stanford University
Presentation Number: 1783eP
Epigenomic cancer detection and the relationship with circulating tumor allele fraction
Presenter: Zaed Hamady, University Hospital Southampton
Presentation Number: 246eP
Epigenomic measurement of tumor fraction contributions to cfDNA in a multicancer test
Presenter: Martin Sjöström, Lund University
Presentation Number: 212eP
Epigenomic liquid biopsy for quantification of platinum and PARP inhibitor response in patients with germ line BRCA-associated PDAC
Presenter: Talia Golan, Sheba Medical Center
Presentation Number: 2270eP